Cancer Biology & Medicine


Cancer Biology & Medicine

Cancer Biology & Medicine is a peer-reviewed open-access journal published by the Chinese Anti-cancer Association (CACA), which is the leading professional society of oncology in China. Published quarterly, the journal provides innovative andsignificant information on the biological basis of cancer, cancer microenvironment, translational cancer research, and all aspects of clinical cancer research. The journal also publishes significant perspectives on indigenous cancer types in China. The scope covers the following topics:

● Cancer genetics

● Cancer and stem cell biology

● Molecular and clinical immunology

● Cancer prevention and epidemiology

● Cancer biomarkers

● Radiation oncology

● Oncology clinical trials

● Mechanisms of drug sensitivity and resistance

● Targeted therapy and immunotherapy

● Multidisciplinary treatment and personalized medicine

Author Benefits

● Easy submission via online system

● Efficient and professional peer review

● Rapid pre-print online publication

● No charge for publication and open access

● International visibility-All full texts are free in PubMed Central




2016 AACR New Horizons in Cancer Research Conference: Delivering Cures Through Cancer Science


American Association for Cancer Research (AACR) "New Horizons in Cancer Research Conference: Delivering Cures Through Cancer Science" will be held from November 2-5, 2016, in Shanghai, China.

Here is the link to the official website of the conference:

Posted: 2016-08-11

First International Conference on Cancer Precision Medicine


First International Conference on Cancer Precision Medicine will be held on Sept. 22nd-24th, 2016 in Tianjin, China.

Please visit the official website of the conference to learn about the program and other detailed information.

Posted: 2016-07-18
More Announcements...

Vol 13, No 2: June 2016 (Special Issue on Tumor Immunology)

Table of Contents


Programmed cell death ligand-1 (PD-L1) expression by immunohistochemistry: could it be predictive and/or prognostic in non-small cell lung cancer? PDF
Mari Mino-Kenudson 157-170
Immuno-oncology combinations: raising the tail of the survival curve PDF
Samuel J. Harris, Jessica Brown, Juanita Lopez, Timothy A. Yap 171-193
Nonmuscle invasive bladder cancer: a primer on immunotherapy PDF
Mahir Maruf, Sam J. Brancato, Piyush K. Agarwal 194-205
Relationship of VEGF/VEGFR with immune and cancer cells: staggering or forward? PDF
Yu-Ling Li, Hua Zhao, Xiu-Bao Ren 206-214
Liquid biopsies for liquid tumors: emerging potential of circulating free nucleic acid evaluation for the management of hematologic malignancies PDF
Jay Hocking, Sridurga Mithraprabhu, Anna Kalff, Andrew Spencer 215-225
New generation of breast cancer clinical trials implementing molecular profiling PDF
Dimitrios Zardavas, Martine Piccart-Gebhart 226-235
Genetic and molecular changes in ovarian cancer PDF
Robert L Hollis, Charlie Gourley 236-247
Bone marrow niche-mediated survival of leukemia stem cells in acute myeloid leukemia: Yin and Yang PDF
Hong-Sheng Zhou, Bing Z. Carter, Michael Andreeff 248-259
Characterization of FGFR signaling pathway as therapeutic targets for sarcoma patients PDF
Wen-Ya Zhou, Hong Zheng, Xiao-Ling Du, Ji-Long Yang 260-268
Influence of obesity and bariatric surgery on gastric cancer PDF
Anna Carolina Batista Dantas, Marco Aurelio Santo, Roberto de Cleva, Rubens Antônio Aissar Sallum, Ivan Cecconello 269-276

Original Article

Modulation of B-cell receptor and microenvironment signaling by a guanine exchange factor in B-cell malignancies PDF
Wei Liao, Sanjai Sharma 277-285
The oncofetal protein IMP3 is an indicator of early recurrence and poor outcome in mucoepidermoid carcinoma of salivary glands PDF
Mohamed R. Elshafey, Rehab A. Ahmed, Mohamed I Mourad, Essam T. Gaballah 286-295